| Authors: |
Gebhart G; Nuclear Medicine Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Keyaerts M; Vrije Universiteit Brussel, Brussels, Belgium., Guiot T; Nuclear Medicine Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Flamen P; Nuclear Medicine Department, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Ruiz-Borrego M; Hospital Universitario Virgen del Rocío, Seville, Spain., Stradella A; Medical Oncology Department, Institut Català D'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Bermejo B; Hospital Clínico Universitario de Valencia, Valencia, Spain., Escriva-de-Romani S; Breast Cancer Group, Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Calvo Martínez L; Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Ribelles N; UGC Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Instituto de Investigaciones Biomédicas de Málaga, Málaga, Spain., Fernandez-Abad M; Medical Oncology Department, Ramón y Cajal Hospital, Madrid, Spain.; Alcala de Henares Medical University, Alcala de Henares, Madrid., Albacar C; Hospital Universitari Sant Joan de Reus, Reus, Spain., Colleoni M; IEO, European Institute of Oncology IRCCS, Milan, Italy., Garrigos L; Hospital Universitari Dexeus, Barcelona, Spain., Atienza de Frutos M; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Dalenc F; Institut Claudius Regaud, IUCT-Oncopole, Toulouse Cancer Research Centre, INSERM, Toulouse, France., Prat A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies Group, IDIBAPS, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Marmé F; Medical Faculty Mannheim Heidelberg University, University Hospital Mannheim, Heidelberg, Germany., Schmid P; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Barts Hospital NHS Trust, London, United Kingdom., Kerrou K; Nuclear Medicine and PET Center Department, Tenon Hospital IUC-UPMC, APHP, Sorbonne University, Paris, France., Braga S; Hospital Vila Franca de Xira and Hospitals CUF Institute José de Mello Saúde, Lisbon, Portugal., Gener P; Medica Scientia Innovation Research, Barcelona, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research, Barcelona, Spain.; International Breast Cancer Center, Quiron Group, Pangaea Oncology, Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Pérez-García JM; Medica Scientia Innovation Research, Barcelona, Spain.; International Breast Cancer Center, Quiron Group, Pangaea Oncology, Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research, Barcelona, Spain; antonio.llombart@maj3.health.; Hospital Universitario Arnau de Vilanova, Universidad Católica de Valencia, Valencia, Spain. |
